Resistance to Tyrosine Kinase Inhibitors - Resistance to Targeted Anti-Cancer Therapeutics - - Books - Springer International Publishing AG - 9783319834382 - April 30, 2018
In case cover and title do not match, the title is correct

Resistance to Tyrosine Kinase Inhibitors - Resistance to Targeted Anti-Cancer Therapeutics Softcover reprint of the original 1st ed. 2016 edition

Price
$ 155.49
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jul 14 - 20

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Not rated yet

Also available as:

The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will then detail resistance to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3, angiokinase family members, and ALK inhibitors.

188 pages, 5 Tables, color; 6 Illustrations, color; 2 Illustrations, black and white; XIII, 188 p. 8

Media Books     Paperback Book   (Book with soft cover and glued back)
Released April 30, 2018
ISBN13 9783319834382
Publishers Springer International Publishing AG
Pages 188
Dimensions 150 × 220 × 10 mm   ·   290 g
Language German  
Editor Focosi, Daniele

Mere med samme udgiver